Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, tolerability, and PK (Pharmacokinetics)
of single oral doses of JTT-251 in healthy and type 2 diabetes mellitus subjects and to
evaluate the effect of food on the PK of JTT-251 in healthy subjects.